- New Boston Scientific distribution partnership now underway - - Conference call today at 5:00 p.m. ET / 2:00 p.m. PT - SILVER SPRING, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today reported strong first-quarter results for 2025 and highlighted key developments driving the adoption of EluPro™. In its first quarter post-launch, EluPro demonstrated strong momentum, establishing its position as a groundbrea ...

Elutia Inc. (NASDAQ:ELUT) Q4 2024 Earnings Conference Call March 6, 2025 4:30 PM ET Company Participants David Carey – FINN Partners C. Randal Mills – Chief Executive Officer Matt Ferguson – Chief Financial Officer Conference Call Participants Ross Osborn – Cantor Fitzgerald Frank Takkinen – Lake Street Capital Markets Operator Good afternoon, ladies and gentlemen. Welcome to the Elutia Inc. Fourth Quarter and Full Year 2024 Financial Results Conference Call. Please be advised that today's conference call i ...